Close Menu

NEW YORK (GenomeWeb) – University of Maryland startup Biomecite Diagnostics has exclusively optioned the rights from UM Baltimore to develop molecular diagnostics to detect inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

The deal between Biomecite and University of Maryland Ventures covers technology developed by Florian Fricke and James White at the University of Maryland School of Medicine's Institute for Genome Sciences. The technology links distinctive genomic variants in the human gut microbiome to the two related, but unique forms of IBD.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.